System Monitors Neurologic and Other Indices

A new neurologic monitoring system uses a combination of electronic and fiber-optic technologies to display a number of clinical indices, including autoregulation status, vasoreactivity and cerebrovascular resistance. The system has been cleared by the US Food and Drug Administration (FDA).

Called NeuroSensor, the system is intended for use by neurosurgeons and neurosurgical intensive care specialists. Currently, by Novus Monitoring Ltd. (Chicago, IL, USA).

"A combination of improved ICP monitoring technology and continuous cerebral blood flow measurement in the NeuroSensor system has made it possible to display and analyze a variety of important and previously unavailable clinical indicators,” said John I. Miller, M.D., neurosurgical patients, including those suffering from traumatic brain injury and cerebrovascular disease, are managed in part by the monitoring of intracranial pressure (ICP). The system was developed neurosurgeon at Catholic Medical Center (New York, NY, USA) and former president of the New York Neurosurgical Association.